Back | Next |
home / stock / embi / embi message board
Subject | By | Source | When |
---|---|---|---|
why are we up ?? | 1plus1 | investorshub | 12/18/2020 7:09:42 PM |
and again added | Dutchpaul1 | investorshub | 12/16/2020 8:45:10 PM |
and again added | Dutchpaul1 | investorshub | 12/16/2020 8:40:45 PM |
added again | Dutchpaul1 | investorshub | 12/15/2020 6:30:17 PM |
took pos today | Dutchpaul1 | investorshub | 12/14/2020 3:05:35 PM |
Rock n roll embi | Kroozer1 | investorshub | 12/04/2020 7:05:54 PM |
Can we have some buy volume now please | Darkchief | investorshub | 12/04/2020 2:45:01 PM |
This stock trades so weird... | BrophInvest | investorshub | 12/03/2020 11:27:07 PM |
$EMBI Now Pink Current | Golden Cross | investorshub | 12/03/2020 10:23:15 AM |
waiting on it patiently for the correction | Darkchief | investorshub | 12/01/2020 3:07:34 PM |
Anything new here? Seems like its just trading | 2014shelby | investorshub | 11/23/2020 5:37:28 PM |
just pumping this stock | Darkchief | investorshub | 11/23/2020 4:46:48 PM |
Is there anyone here ? | Darkchief | investorshub | 11/19/2020 8:53:55 PM |
Hindsight... Where's the bottom? | Southern Gal | investorshub | 09/30/2020 1:41:29 PM |
Just got 30,000 shares at 0.0450 Ya just never know??! | Joemarly | investorshub | 09/10/2020 3:30:55 PM |
House to vote on marihuana rescheduling the week | N.C.LUCKY(7) | investorshub | 09/03/2020 4:11:10 AM |
Pretty large insider buying from the new CEO. | Vipyr | investorshub | 08/12/2020 7:21:04 PM |
Buy at a nickle. | willlbone | investorshub | 07/31/2020 6:53:45 PM |
a lot of movement the last few days, | newguy49 | investorshub | 06/29/2020 9:05:18 PM |
Most of these companies have massive dilution. Id | Vinpat | investorshub | 02/13/2020 9:07:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Emerald Bioscience Inc Company Name:
EMBI Stock Symbol:
OTCMKTS Market:
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with si...